CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals.
CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals. Knoxville, TN-based CPS will provide an ECAT PET scanner.
Sparked by Mobile PET Systems successful debut of mobile PET services at the October European Association of Nuclear Medicine meeting in Barcelona, Spain, the deal makes San Diego, CA-based Mobile PET the first company to provide mobile ECAT PET imaging technology in Europe, the two firms said. Mobile PET expects to begin service within the next three months through Mobile PET Systems Europe, a joint venture it formed with Neuromed of Germany.
The deal adds to the momentum Mobile PET has been enjoying since December 1998 when the company went public, bolstered by a favorable reimbursement market for PET. In February, the firm bought five mobile coaches from Calumet Coach of Calumet City, IL, expanding its service capability, and in March, received a $10 million line of credit from Finova Capital, which it has used to cover the purchase of five Siemens ECAT Exact PET cameras (SCAN 2/17/99 and 3/31/99).
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.